Published in
Taylor and Francis Group, Leukemia & Lymphoma, 3(63), p. 729-737, 2021
DOI: 10.1080/10428194.2021.1998484
Links
Tools
Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine
Journal article published in 2021 by
Christina-Nefeli Kontandreopoulou,
Panagiotis T. Diamantopoulos,
Andreas Giannopoulos,
Argiris Symeonidis,
Ioannis Kotsianidis,
Vasiliki Pappa,
Athanasios Galanopoulos,
Panayiotis Panayiotidis,
Maria Dimou 
,
Elena Solomou,
Theodoros Loupis,
Katerina Zoi,
Nefeli Giannakopoulou,
Georgios Dryllis,
Sevastianos Hatzidavid
and other authors.
,
Elena Solomou,
Theodoros Loupis,
Katerina Zoi,
Nefeli Giannakopoulou,
Georgios Dryllis,
Sevastianos Hatzidavid
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 